Figure 6 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases

Figure 6 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases

<p>Topographic immune cell deconvolution primary colorectal cancer and CRLM. <b>A,</b> Images (from <a href="#fig4" target="_blank">Fig. 4A</a>) of primary colorectal cancer (bottom) and CRLM (top) with 48 ROIs superimposed. Abundance estimates as de...

保存先:

書誌詳細
第一著者:	Colin S. Wood (15293247) (author)
その他の著者:	Kathryn A.F. Pennel (15293250) (author), Holly Leslie (15293253) (author), Assya Legrini (15293256) (author), Andrew J. Cameron (15046037) (author), Lydia Melissourgou-Syka (15293259) (author), Jean A. Quinn (15293262) (author), Hester C. van Wyk (15293265) (author), Jennifer Hay (15293268) (author), Antonia K. Roseweir (15293271) (author), Colin Nixon (14949516) (author), Campbell S.D. Roxburgh (15293274) (author), Donald C. McMillan (15293277) (author), Andrew V. Biankin (14937726) (author), Owen J. Sansom (14949234) (author), Paul G. Horgan (15293280) (author), Joanne Edwards (14939606) (author), Colin W. Steele (15293283) (author), Nigel B. Jamieson (15046064) (author)
出版事項:	2025
主題:	Cancer Tumor Biology Cancer Detection and Diagnosis Methods and Technology Biomarkers Diagnostic biomarkers Gastrointestinal Cancers Colorectal cancer Gene Technologies High-throughput sequencing Progression, Invasion & Metastasis
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Figure 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
著者:: Colin S. Wood (15293247)
出版事項: (2025)

Figure 2 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
著者:: Colin S. Wood (15293247)
出版事項: (2025)

Figure 3 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
著者:: Colin S. Wood (15293247)
出版事項: (2025)

Figure 4 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
著者:: Colin S. Wood (15293247)
出版事項: (2025)

Figure 5 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
著者:: Colin S. Wood (15293247)
出版事項: (2025)

Table 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
著者:: Colin S. Wood (15293247)
出版事項: (2025)

Supplementary Table 4: SpatialDecon derived immune cell counts from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
著者:: Colin S. Wood (15293247)
出版事項: (2025)

Supplementry Table 3: REACTOME Gene Set Enrichment Analysis results from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
著者:: Colin S. Wood (15293247)
出版事項: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
著者:: Anuja Sathe (15028097)
出版事項: (2025)

Supplementary Tables S1-S15 from Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
著者:: Iris van 't Erve (15054503)
出版事項: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
著者:: Shuwei Li (16437116)
出版事項: (2025)

Supplementary table S2 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
著者:: Leon P. Loevenich (14963948)
出版事項: (2025)

Supplementary table S3 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
著者:: Leon P. Loevenich (14963948)
出版事項: (2025)

Supplementary table S4 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
著者:: Leon P. Loevenich (14963948)
出版事項: (2025)

Supplementary video file from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
著者:: Leon P. Loevenich (14963948)
出版事項: (2025)

Supplementary Figure S7 from <i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer
著者:: Katleen Janssens (15053356)
出版事項: (2025)

Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
著者:: Carlotta Antoniotti (15352506)
出版事項: (2025)

Supplementary Figure S2 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
著者:: Carlotta Antoniotti (15352506)
出版事項: (2025)

Supplementary Figure S3 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
著者:: Carlotta Antoniotti (15352506)
出版事項: (2025)

Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
著者:: Subhamoy Chakraborty (16648124)
出版事項: (2025)

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
著者:: Subhamoy Chakraborty (16648124)
出版事項: (2025)

Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
著者:: Subhamoy Chakraborty (16648124)
出版事項: (2025)

Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
著者:: Subhamoy Chakraborty (16648124)
出版事項: (2025)

Supplementary Table S1 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
著者:: Nan Deng (17314330)
出版事項: (2025)

Supplementary Table S2 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
著者:: Nan Deng (17314330)
出版事項: (2025)

Supplementary Table S3 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
著者:: Nan Deng (17314330)
出版事項: (2025)

Supplementary Table S4 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
著者:: Nan Deng (17314330)
出版事項: (2025)

Supplementary Table S5 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
著者:: Nan Deng (17314330)
出版事項: (2025)

Supplementary Table S6 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
著者:: Nan Deng (17314330)
出版事項: (2025)

Supplementary Table S7 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
著者:: Nan Deng (17314330)
出版事項: (2025)

Supplementary Table S8 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
著者:: Nan Deng (17314330)
出版事項: (2025)

Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
著者:: Raphaël Leman (17314506)
出版事項: (2025)

Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
著者:: Raphaël Leman (17314506)
出版事項: (2025)

Supplementary Table S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
著者:: Raphaël Leman (17314506)
出版事項: (2025)

Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
著者:: Raphaël Leman (17314506)
出版事項: (2025)

Supplementary Table S5 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
著者:: Raphaël Leman (17314506)
出版事項: (2025)

Supplementary Table S6 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
著者:: Raphaël Leman (17314506)
出版事項: (2025)

Supplementary Figures 1 from Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
著者:: Luana Guimaraes Sousa (16534377)
出版事項: (2025)

Supplementary Data 1 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
著者:: Priyanka Gopal (15050862)
出版事項: (2025)

Supplementary Data 2 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
著者:: Priyanka Gopal (15050862)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_o2kn1dvnrj61bv2hkst5nkc1dm